Search Results - "Carrascosa Carrillo, Jose Manuel"
-
1
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Published in International journal of molecular sciences (23-06-2021)“…The paradigm of psoriasis as a Th17-driven disease has evolved in the last years towards a much deeper knowledge of the complex pathways, mechanisms, cells,…”
Get full text
Journal Article -
2
Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
Published in Annals of medicine (Helsinki) (01-01-2021)“…To critically analyse and define therapeutic objectives, response to treatment evaluation and related decisions in psoriasis. Expert consensus meetings, a…”
Get full text
Journal Article -
3
Sodium metabisulfite a current low relevant allergen in Spain
Published in Journal of the European Academy of Dermatology and Venereology (01-06-2024)Get full text
Journal Article -
4
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation
Published in Contact dermatitis (01-03-2023)“…Background Current frequency and risk factors for sensitization to methylisothiazolinone (MI), methylchloroisothiazolinone/methylisothiazolinone (MCI/MI),…”
Get full text
Journal Article -
5
Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain
Published in Journal of the European Academy of Dermatology and Venereology (01-03-2023)Get full text
Journal Article -
6
An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)
Published in Contact dermatitis (01-11-2024)“…Background Reports of allergic contact dermatitis (ACD) to phytonadione epoxide (PE) in cosmetics suggest that PE is as powerful a sensitiser as its parent…”
Get full text
Journal Article -
7
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Published in Contact dermatitis (01-05-2024)“…A global epidemic of allergic contact dermatitis to (meth)acrylates has been described in relation to the widespread use of manicure products. To evaluate the…”
Get full text
Journal Article -
8
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment
Published in Dermatology and therapy (01-05-2022)“…Introduction As research continues, new drugs will no doubt be added to the current pool of treatments for moderate-to-severe atopic dermatitis (AD). This…”
Get full text
Journal Article -
9
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
Published in Acta dermato-venereologica (25-03-2022)“…Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients' quality of life. The aim of this study was to…”
Get full text
Journal Article -
10
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Published in Frontiers in public health (26-01-2023)“…Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e., response)…”
Get full text
Journal Article -
11
-
12
Ixekizumab for the treatment of erythrodermic psoriasis triggered by durvalumab-tremelimumab in a cancer patient
Published in EJD. European journal of dermatology (26-08-2021)Get full text
Journal Article -
13
Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22 , 6740
Published in International journal of molecular sciences (28-02-2022)“…In the original publication [...]…”
Get full text
Journal Article -
14
Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023
Published in Contact dermatitis (12-10-2024)“…Patch test results may be influenced by age-related factors. However, there is still discordant evidence between age and patch test results. We aim to evaluate…”
Get full text
Journal Article -
15
Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022)
Published in Contact dermatitis (01-05-2024)“…Current frequency and features for positivity to textile dye mix (TDM) in Spain are unknown. To study the frequency, clinical features and simultaneous…”
Get full text
Journal Article -
16
Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain
Published in Dermatologic therapy (10-07-2024)“…Background . Current psoriasis treatment goals emphasize achieving complete or near‐complete skin clearance while preserving the quality of life, necessitating…”
Get full text
Journal Article -
17
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
Published in Contact dermatitis (01-01-2018)“…Summary Background Corticosteroids are among the most commonly used topical drugs. Contact allergy to these exists, but can be easily missed. Corticosteroid…”
Get full text
Journal Article -
18
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines
Published in The Journal of dermatological treatment (03-04-2022)“…Response to treatments in psoriasis can be assessed using the PASI response 50, 75, 90 or 100. Achieving a PASI 100 response would mean a complete resolution…”
Get full text
Journal Article -
19
Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022)
Published in Contact dermatitis (01-05-2024)“…BackgroundCurrent frequency and features for positivity to textile dye mix (TDM) in Spain are unknown.ObjectivesTo study the frequency, clinical features and…”
Get full text
Journal Article -
20
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
Published in British journal of dermatology (1951) (01-03-2017)“…Summary Background Information on the safety of tumour necrosis factor (TNF) antagonists frequently arises from their use in rheumatic diseases, their first…”
Get full text
Journal Article